Node-positive Breast Cancer: Clinical Trials

11 trials for Node-positive Breast Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 2 active not recruiting, 2 unknown, 1 completed. 5 Not applicable, 3 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5Active not recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1
Phase 23Recruiting 3
Phase 42Recruiting 1, Unknown 1

Follow Node-positive Breast Cancer: new trials by email Literature Review of Node-positive Breast Cancer trials Research Report on Node-positive Breast Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients
Axillary Lymph Node Dissection, Axillary Reverse Mapping, Lymphaticovenous Bypass - Node-positive Breast Cancer
Not applicableNot yet recruitingCase Comprehensive Cancer Center4002026-06-012026-02-19
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
Neoadjuvant Pembrolizumab, low dose neoadjuvant boost, High dose neoadjuvant boost - Breast Cancer, Triple Negative Breast Cancer (TNBC)
Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center322026-03-172026-04-27
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
CT Scan - Breast Cancer, Node-positive Breast Cancer
Phase 2RecruitingH. Lee Moffitt Cancer Center and Research Institute1202025-02-242026-07-02
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer
Hypofractionated radiation, Ultra-hypofractionated breast/chest wall and regional nodal radiation - Node-positive Breast Cancer
Phase 2RecruitingWashington University School of Medicine2202024-08-272026-01-09
Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy
Targeted axillary lymph node dissection - Node-positive Breast Cancer
Phase 4UnknownAssiut University302023-12-012023-01-09
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
Ovarian function suppression with endocrine treatments - Breast Cancer, Estrogen Receptor Positive Tumor
Phase 4RecruitingGangnam Severance Hospital4182023-02-062025-05-22
TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
Targeted axilllary dissection (TAD) followed by axillary lymph node dissection (ALND) - Breast Cancer, Node-positive Breast Cancer
RecruitingKliniken Essen-Mitte1502022-03-072023-02-15
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
PET/MRI - Breast Cancer Female, Node-positive Breast Cancer
Not applicableCompletedIRCCS San Raffaele1092019-11-042025-08-01
MUltimodal Targeted Axillary Surgery
Systematic axillary ultrasound imaging, Sentinel node, Excision of suspicious lymph nodes - Node-positive Breast Cancer
Not applicableUnknownParc de Salut Mar1602019-10-232021-10-15
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
Tailored axillary surgery - both Arms, Radiotherapy - Arm A, Radiotherapy - Arm B - Node-positive Breast Cancer
Not applicableActive not recruitingUniversity Hospital, Basel, Switzerland15002018-08-072026-05-01
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
External Beam Radiation Therapy - Breast Cancer, Node-positive Breast Cancer
Not applicableActive not recruitingVirginia Commonwealth University1372015-08-042026-06-15

Narrower conditions

Breast Neoplasms (7)  ·  Breast Carcinoma In Situ (1)  ·  Triple Negative Breast Neoplasms (1)

Broader conditions

Breast Diseases (7)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Carcinoma (1)  ·  Carcinoma in Situ (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

DAT protocol 1 (1)  ·  Radiation Dose Hypofractionation (1)  ·  Sentinel Lymph Node Biopsy (1)

Sponsors

Assiut University (1)  ·  Case Comprehensive Cancer Center (1)  ·  Gangnam Severance Hospital (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  IRCCS San Raffaele (1)  ·  Kliniken Essen-Mitte (1)  ·  Parc de Salut Mar (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University Hospital, Basel, Switzerland (1)  ·  Virginia Commonwealth University (1)  ·  Washington University School of Medicine (1)

Countries

United States (5)  ·  Germany (2)  ·  Italy (2)  ·  South Korea (2)  ·  Argentina (1)  ·  Austria (1)  ·  Canada (1)  ·  Croatia (1)  ·  Greece (1)  ·  Hungary (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Dana Casey, MD (1)  ·  Douglas W Arthur, M.D. (1)  ·  Julie E Lang, MD, FACS (1)  ·  Kamran Ahmed (1)  ·  Maria Thomas, M.D., Ph.D. (1)  ·  Maria Vernet-Tomas, MD, PhD (1)  ·  Mattea Reinisch, Dr. (1)  ·  Matthew Mills (1)  ·  Sherko Kuemmel, Prof. Dr. (1)  ·  Sung Gwe Ahn, M.D.,Ph.D. (1)  ·  Walter P. Weber, Prof. (1)

Results publications

PMID 30514362, PMID 34555676, PMID 37355526, PMID 37903951, PMID 41612658, PMID 42394696, PMID 42492092

NIH funding

2018 (1), R01CA274254 (1)